Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.56 |
| ▸ | TYR | P14679 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5167885 | 0.90 | TYR (0.67) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL5168590 | 0.90 | TYR (0.61) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL5167232 | 0.89 | TRPA1 (0.59) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL50708 | 0.89 | CNR1 (0.59) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL5168102 | 0.89 | CNR1 (0.59) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL6561766 | 0.88 | BACE1 (0.61) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL10666157 | 0.84 | MAPT (0.51) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL10666145 | 0.84 | ALOX15 (0.51) | CNR1CNR2ALOX5TYRCYP3A4 | |
| SCHEMBL83606 | 0.83 | TYR (0.69) | ALOX5TYRCYP3A4TSHRMEN1 | |
| SCHEMBL5164462 | 0.83 | GABRA1 (0.58) | CNR1CNR2ALOX5TYRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421349-B2 | Polyphenylene ether composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-09-23 | — | — | US | disclosed |
| CN-120118458-A | Curable composition, resin, and cured product | 东京应化工业株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-119937242-A | Photosensitive resin composition | 东京应化工业株式会社 | 2025-05-06 | — | — | CN | disclosed |
| CN-114514261-B | Polyphenylene ether composition | 旭化成株式会社 | 2024-09-10 | — | — | CN | disclosed |
| CN-117327362-A | Curable resin composition | 东京应化工业株式会社 | 2024-01-02 | — | — | CN | disclosed |
| CN-117229495-A | Polyphenylene ether, method for producing the same, thermosetting composition, prepreg, and laminate | 旭化成株式会社 | 2023-12-15 | — | — | CN | disclosed |
| CN-117215149-A | Photosensitive resin composition | 东京应化工业株式会社 | 2023-12-12 | — | — | CN | disclosed |
| EP-4039728-B1 | POLYPHENYLENE ETHER COMPOSITION | ASAHI CHEMICAL IND (JP) | 2023-10-11 | — | — | EP | disclosed |
| CN-112812291-B | Hydrogenated polyphenylene ether and process for producing the same | 旭化成株式会社 | 2023-07-18 | — | — | CN | disclosed |
| WO-2022239631-A1 | NOVEL TERMINAL-MODIFIED POLYPHENYLENE ETHER AND TERMINAL-MODIFIED POLYPHENYLENE ETHER COMPOSITION | 旭化成株式会社 | 2022-11-17 | — | — | WO | disclosed |
| US-6884814-B2 | Phenyl benzisoxazoles as estrogenic agents | WYETH (US) | 2005-04-26 | — | — | US | disclosed |
| US-6841650-B2 | Crystallizable poly (2,5-di-substituted-1,4-phenylene oxide) and a method of preparing the same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2005-01-11 | — | — | US | disclosed |
| WO-2004108642-A1 | METHOD FOR PRODUCING 2,2'-DIHYDROXY-BIPHENYLS | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-16 | — | — | WO | disclosed |
| WO-2004069779-A1 | METHOD FOR PRODUCING 2,2'-DIHYDROXYBIPHENYLS | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-19 | — | — | WO | disclosed |
| EP-1029882-B1 | A crystallizable poly(2,5-di-substituted-1, 4-phenylene oxide) and a method of preparing the same | NAT INST OF ADVANCED IND SCIEN (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-20030207927-A1 | Phenyl benzisoxazoles as estrogenic agents | WYETH | 2003-11-06 | — | — | US | disclosed |
| US-6541596-B1 | Subjecting a 2,5-di- substituted phenol to oxidative polymerization in the presence of oxygen and a copper complex catalyst composed of tridentate ligand of which nitrogen atoms are coordiante to a copper atom | SECRETARY OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY | 2003-04-01 | — | — | US | disclosed |
| US-20020183475-A1 | Crystallizable poly (2,5-di-substituted-1,4-phenylene oxide) and a method of preparing the same | SECRETARY OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY | 2002-12-05 | — | — | US | disclosed |
| EP-1029882-A2 | A crystallizable poly(2,5-di-substituted-1, 4-phenylene oxide) and a method of preparing the same | Secretary of Agency of Industrial Science and Technology (JP) | 2000-08-23 | — | — | EP | disclosed |
| US-4360469-A | Preparation of quinones by salcomine-catalyzed oxidation of phenols | EASTMAN KODAK COMPANY (US) | 1982-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207927-A1 | Phenyl benzisoxazoles as estrogenic agents | ESR1, ESR2, GPER1 | CNR1 194/4885CNR2 370/4885ALOX5 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.